MDT Medtronic

Q1 2025 10-Q

Filed: Feb 25, 2025Period ending Jan 24, 2025

Health Care

Electromedical & Electrotherapeutic ApparatusSEC EDGAR

Medtronic (MDT) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Feb 25, 2025 for the fiscal period ending Jan 24, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q1 2025 10-Q

Risk Factors

• No newly added risk factors this quarter; risk section largely unchanged from the prior 10-K
• Pricing pressure risk updated with increased emphasis on decreasing selling prices impacting margins

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$7.9B

Net Income

$1.0B

Operating Margin

16.1%

Net Margin

13.2%

Source: XBRL data from Medtronic Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Medtronic Quarterly Reports

Q1 2026 10-Q

Q4 2025 10-Q

Get deeper insights on Medtronic

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.